Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant in Diabetic Patients With Low-Renin Hypertension
NCT02811055Phase 2Completed
- Sponsor
- Rouen University Hospital
- Start
- Jul 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in hypertension (HTN) comparing Aprepitant with Placebo (2 arms). Primary endpoint: Difference from baseline in Plasma aldosterone concentration at Day 14. Started Jul 2017; status: completed.
02
Drugs
aprepitant
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02811055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811055.